Abstract
When a child requires aortic valve replacement (AVR), prosthetic valve options are limited and suboptimal because there is no valve substitute that is capable of providing lifelong durability, optimal hemodynamics, zero thrombogenicity, and the potential to grow with the child. The only option that provides a living valve substitute is the Ross procedure, at the cost of double prosthetic valve disease. Children should grow up being able to live life to the fullest, but the harsh reality is that kids who undergo AVR—regardless the valve type implanted—face many challenges in doing so.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
